Literature DB >> 2532558

D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.

H A Robertson1, M R Peterson, K Murphy, G S Robertson.   

Abstract

L-Dopa and dopaminergic agonists selective for the D1- or D2-dopamine receptor subtype induce contraversive rotation in rats which have been unilaterally lesioned with injections of 6-hydroxydopamine (6-OHDA) into the substantia nigra. D-Amphetamine, which releases dopamine from neurones on the unlesioned side of the animal, causes ipsiversive rotation. These increases in rotational behaviour are mediated, at least in part, by dopamine receptors in the striatum. In unilaterally lesioned animals, L-dopa and the D1-selective agonists SKF 38393 and CY 208-243 produce contralateral rotation and induction of the nuclear proto-oncogene c-fos in the lesioned striatum. D-Amphetamine induces both ipsilateral rotation and c-fos activation in the intact striatum. Three lines of evidence, however, dissociate fos induction and rotation. First, LY 171555, a selective D2-dopamine receptor agonist, also induces contraversive rotation but this rotation is not accompanied by c-fos activation in striatum. Second, D1-dopamine agonists produce activation of striatal c-fos even if rotation is prevented by an anaesthetic. Third, rotation induced by injection of SKF 38393 into substantia nigra is not accompanied by c-fos induction. These results suggest a mechanism by which D1-dopamine receptor mechanisms may regulate long-term changes in dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532558     DOI: 10.1016/0006-8993(89)91689-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

Review 1.  Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.

Authors:  J P Doucet; S P Squinto; N G Bazan
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

2.  The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.

Authors:  M Zivin; L Sprah; D Sket
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson.

Authors:  M Morelli; S Fenu; A Pinna; A Cozzolino; G Di Chiara
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

4.  Fos and glutamate AMPA receptor subunit coexpression associated with cue-elicited cocaine-seeking behavior in abstinent rats.

Authors:  A R Zavala; S Biswas; R E Harlan; J L Neisewander
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

Review 5.  The molecular biology of addictive drugs.

Authors:  S A Mackler; J H Eberwine
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

6.  Social stress in hamsters: defeat activates specific neurocircuits within the brain.

Authors:  S Kollack-Walker; S J Watson; H Akil
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

7.  Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

Authors:  J L Labandeira-Garcia; G Rozas; E Lopez-Martin; I Liste; M J Guerra
Journal:  Exp Brain Res       Date:  1996-02       Impact factor: 1.972

8.  Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.

Authors:  K J Page; B J Everitt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.

Authors:  G J LaHoste; J Yu; J F Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 10.  Role of monoamine systems in activation of zif268 by cocaine.

Authors:  R V Bhat; A J Cole; J M Baraban
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.